Quantcast
Home > Quotes > FIXX
FIXX

Homology Medicines, Inc. Common Stock (FIXX) Quote & Summary Data

$24.28
*  
0.35
1.46%
Get FIXX Alerts
*Delayed - data as of Dec. 14, 2018  -  Find a broker to begin trading FIXX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    FIXX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
30
Today's High / Low
$ 24.77 / $ 23.60
Share Volume
104,388
50 Day Avg. Daily Volume
135,305
Previous Close
$ 23.93
52 Week High / Low
$ 26.50 / $ 15.07
Market Cap
910,397,368
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.75

Intraday Chart

Shares Traded

Share Volume:
104,388
50 Day Avg. Daily Volume:
135,305

Trading Range

The current last sale of $24.28 is 61.11% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 24.77 $ 26.50
 Low: $ 23.60 $ 15.07

Company Description (as filed with the SEC)

We are a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Our proprietary platform is designed to utilize our human hematopoietic stem cell derived adeno-associated virus vectors, or AAVHSCs, to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. The unique properties of our proprietary suite of 15 novel AAVHSCs enable us to focus on a method of gene editing called gene correction, either through the replacement of an entire diseased gene in the genome with a whole functional copy or the precise repair of individual mutated nucleotides, by harnessing the naturally occurring DNA repair process of homologous recombination, or HR.  ... More ...  


Risk Grade

Where does FIXX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 23.82
Open Date:
Dec. 14, 2018
Close Price:
$ 24.28
Close Date:
Dec. 14, 2018

Consensus Recommendation

Analyst Info